Benzazole derivatives, compositions, and methods of use as B-secretase inhibitors
AU2011236055A1
3- (1, 3-benzodioxol-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine H3 receptor antagonist
WO2012015715A1
Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta hsd1 modulators
CA2792339A1
Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors
SG182629A1
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
WO2011022216A1
Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stress
WO2011022207A1
Bis-sulfonamide derivatives, compositions, and methods of use
WO2010126745A1
SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE AS β-SECRETASE INHIBITORS
EP2424533A1
Substituted isoquinoline derivatives, pharmaceutical compositions, and methods of use as -secretase inhibitors
CA2744383A1
Adamantyl benzamide compounds
US2009264412A1
Combination Therapy Using An 11beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor And A Glucocorticoid Receptor Agonist To Minimize The Side Effects Associated With Glucocorticoid Receptor Agonist Therapy
WO2009126782A1
Histamine h3 receptor ligands
US2009264435A1
Novel Aryl- and Heteroarylpiperazines
US2010190808A1
Tricyclic compounds as modulators of TNF-α synthesis
CN101711106A
Pharmaceutical use of substituted amides
CA2681934A1
11beta-hsd1 active compounds
EP2129652A2
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
